Charlie Hospital Semarang Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 1.51M). Which is the better fit depends on your goals.
| RSCH | SWID | |
|---|---|---|
Market Cap | 742B | 490.04B |
Volume | 29.45M | 1.51M |
Lot | 294.49K | 15.14K |
Turnover | 8.14B | 137.63M |
Average Price | 276.35 | 90.94 |
Value | 8.14B | 137.63M |
Indicative Equilibrium Price | 270 | 92 |
Indicative Equilibrium Volume | 103 | 1.49K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →